GLOBAL CEO INITIATIVE

We are excited to share that CEOi's Blood-Based Biomarker Workgroup publication, "The Global CEO Initiative on Alzheimer's Disease performance recommendations for blood-based biomarker tests," is now released in Nature Reviews Neurology... The Global CEO Initiative on Alzheimer's Disease (CEOi), founded in 2013, is an organization of private-sector leaders who have joined together to provide business leadership in the fight against Alzheimer's. The CEOi believes that, during this era of aging populations, it will take visionary, coordinated, goal-oriented leadership of public and private leaders working together to solve our greatest challenges. It is convened by UsAgainstAlzheimer's... We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer's patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

Primary location: Washington United States